257 related articles for article (PubMed ID: 15802344)
1. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia.
Schleicher GK; Herbert V; Brink A; Martin S; Maraj R; Galpin JS; Feldman C
Eur Respir J; 2005 Apr; 25(4):688-92. PubMed ID: 15802344
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
3. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of serum procalcitonin levels in pulmonary tuberculosis.
Ugajin M; Miwa S; Shirai M; Ohba H; Eifuku T; Nakamura H; Suda T; Hayakawa H; Chida K
Eur Respir J; 2011 Feb; 37(2):371-5. PubMed ID: 20530033
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.
Polzin A; Pletz M; Erbes R; Raffenberg M; Mauch H; Wagner S; Arndt G; Lode H
Eur Respir J; 2003 Jun; 21(6):939-43. PubMed ID: 12797485
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin in children admitted to hospital with community acquired pneumonia.
Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
[TBL] [Abstract][Full Text] [Related]
7. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
[TBL] [Abstract][Full Text] [Related]
8. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?
Korppi M
Pediatr Int; 2004 Oct; 46(5):545-50. PubMed ID: 15491381
[TBL] [Abstract][Full Text] [Related]
9. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
10. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
Galetto-Lacour A; Alcoba G; Posfay-Barbe KM; Cevey-Macherel M; Gehri M; Ochs MM; Brookes RH; Siegrist CA; Gervaix A
Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
[TBL] [Abstract][Full Text] [Related]
11. Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia.
Bellmann-Weiler R; Ausserwinkler M; Kurz K; Theurl I; Weiss G
J Clin Microbiol; 2010 May; 48(5):1915-7. PubMed ID: 20220163
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis.
Hedlund J; Hansson LO
Infection; 2000; 28(2):68-73. PubMed ID: 10782390
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y
Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
[TBL] [Abstract][Full Text] [Related]
14. Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP.
Nyamande K; Lalloo UG
Int J Tuberc Lung Dis; 2006 May; 10(5):510-5. PubMed ID: 16704032
[TBL] [Abstract][Full Text] [Related]
15. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis.
Huang CT; Lee LN; Ho CC; Shu CC; Ruan SY; Tsai YJ; Wang JY; Yu CJ
J Infect; 2014 May; 68(5):440-7. PubMed ID: 24393650
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY
Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection.
Ingram PR; Inglis T; Moxon D; Speers D
Intensive Care Med; 2010 Mar; 36(3):528-32. PubMed ID: 20069274
[TBL] [Abstract][Full Text] [Related]
18. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR.
Alcoba G; Keitel K; Maspoli V; Lacroix L; Manzano S; Gehri M; Tabin R; Gervaix A; Galetto-Lacour A
Eur J Pediatr; 2017 Jun; 176(6):815-824. PubMed ID: 28474099
[TBL] [Abstract][Full Text] [Related]
19. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
[TBL] [Abstract][Full Text] [Related]
20. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
